Atea Pharmaceuticals Inc (AVIR)
3.71
+0.02
(+0.54%)
USD |
NASDAQ |
Apr 26, 16:00
3.705
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 60.95% |
| September 30, 2021 | -85.93% |
| June 30, 2021 | 2.55% |
| Date | Value |
|---|---|
| March 31, 2021 | 46.55% |
| December 31, 2020 | 42.47% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-85.93%
Minimum
Sep 2021
60.95%
Maximum
Dec 2021
13.32%
Average
42.47%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |